Recalls / Active ingredient / Omalizumab
Omalizumab
3 FDA drug recalls involving the active ingredient “Omalizumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-07-30 | Class II | Xolair (omalizumab injection), 150 mg/ml, 1 auto-injector, Rx only, Genentech, Inc, South San Francisco, CA 94 | Cardinal Health Inc. |
| 2025-07-30 | Class II | Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDC 5024 | Cardinal Health Inc. |
| 2021-06-09 | Class II | Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For Subcutaneous Use. Single-Dose Pr | Genentech Inc |